Highlights from the 2014 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the end of the HIV pandemic

Alain Lafeuillade (1) , Mark Wainberg (2) , Marie-Lise Gougeon (3) , Sabine Kinloch-De Loes (4) , Philippe Halfon (5) , Hervé Tissot-Dupont (6)

1 Department of Infectious Diseases
2 McGill University = Université McGill [Montréal, Canada]
3 IABV - Immunité Anti-virale, Biothérapie et Vaccins
4 Royal Free Center for HIV Medicine, Department of Infection and Immunity
5 Internal Medicine and Infectious Diseases Department
6 Health Department

The 2014 International Symposium on HIV and Emerging Infectious Diseases (ISHEID) provided a forum for investigators to hear the latest research developments in the clinical management of HIV and HCV infections as well as HIV cure research. Combined anti-retroviral therapy (c-ART) has had a profound impact on the disease prognosis and transformed this infection into a chronic disease. However, HIV is able to persist within the infected host and the pandemic is still growing. The main 2014 ISHEID theme was, hence "Together for a world without HIV and AIDS". In this report we not only give details on this main topic but also summarize what has been discussed in the areas of HCV coinfection and present a short summary on currently emerging viral diseases.

Keywords: HIV; HCV; Hepatitis E; Antiretroviral drugs; HIV vaccine; HIV cure; HIV reservoirs

Domains: Life Sciences [q-bio]; Human health and pathology; Infectious diseases

Alain Lafeuillade, Mark Wainberg, Marie-Lise Gougeon, Sabine Kinloch-De Loes, Philippe Halfon, et al.. Highlights from the 2014 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the end of the HIV pandemic. AIDS Research and Therapy, 2014, 11 (1), pp.28. ⟨10.1186/1742-6405-11-28⟩. ⟨pasteur-01058710⟩